Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDT vs Topical Corticosteroids in Oral Lichen Planus
NCT07536737Completed
- Sponsor
- Medical University of Białystok
- Start
- Sep 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of 5-aminolevulinic acid in oral lichen planus (OLP) (2 arms), sponsored by Medical University of Białystok. Primary endpoint: Change in taste function at Day 35. Started Sep 2021; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT07536737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07536737.